Home›Companies›Biotech & Pharma›Trailhead Biosystems

Trailhead Biosystems Inc.

Human cell products for drug discovery and cell therapy research.

Updated Nov 9, 2026·Latest SEC filing Jul 30, 2026·Suggest an edit

About Trailhead Biosystems

Trailhead Biosystems is a private company based in Beachwood, Ohio. It has reported $62,281,230 raised in five offerings on Form D since June 2020. Its chief executive is David Llewellyn.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 21, 2024Jul 1, 2024amended Jul 30, 2026$40,605,490fully sold7$5.8MConvertible Promissory Note that may convert into shares of capital stock of the issuerRule 506(b)Form D/A ↗4 earlier filings
Nov 9, 2023Nov 20, 2023$3,000,000fully sold2$1.5MEquityRule 506(b)Form D ↗
Sep 16, 2022Sep 26, 2022$9,999,999of $10.0M target6$1.6MEquityRule 506(b)Form D ↗
Oct 28, 2020Nov 9, 2020amended Oct 29, 2021$8,575,741fully sold13$659KEquityRule 506(b)Form D/A ↗1 earlier filing
Jun 4, 2020Jun 18, 2020$100,000of $2.0M target3$33,333Convertible promissory notesRule 506(b)Form D ↗
Total, five offerings$62,281,230

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Trailhead Biosystems's Form D filed Jul 30, 2026.

David Llewellyn
David Llewellyn
President and Chief Executive Officer, director
Michael Kaufman
Michael Kaufman
Chief Executive Officer, MAK Capital and director
Also a director at Noveome Biotherapeutics.
Joshua Snow
Joshua Snow
Chief Commercial Officer
Divya Trivedi
Divya Trivedi
Chief Operating Officer
Craig Nemiroff
Craig Nemiroff
Managing Director, MAK Capital
Also a board member at Noveome Biotherapeutics.
Jan Jensen
Jan Jensen
Board Member, Trailhead Biosystems
HH
Wolfgang Hofmann
Wolfgang Hofmann
Board Member, Trailhead Biosystems

Earlier filings also listed Magnus Persson (director, last listed Nov 2023) and Div Trivedi (executive officer, last listed Oct 2021).

Sources

  1. SECTrailhead Biosystems Inc. Form D/A, filed Jul 30, 2026
  2. SECTrailhead Biosystems Inc. Form D/A, filed Jan 5, 2026
  3. SECTrailhead Biosystems Inc. Form D/A, filed May 12, 2025
  4. SECTrailhead Biosystems Inc. Form D, filed Jul 1, 2024
  5. SECTrailhead Biosystems Inc. Form D, filed Nov 9, 2020
  6. SECTrailhead Biosystems Inc. filing history
  7. CompanyContact
  8. CompanyAbout Trailhead Biosystems
  9. PressTrailhead Biosystems financing announcement